Constitutive nuclear factor-kappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitor-resistant tumour cells

Weiguang Wang, J. Cassidy

    Research output: Contribution to journalArticle

    33 Citations (Scopus)

    Abstract

    In this study, the gene copy number, mRNA and protein expression levels and nuclear DNA-binding activity of nuclear factor kappa B (NF-kappaB) were compared in a panel of five pairs of thymidylate synthase (TS) inhibitor-resistant and wild-type parent cancer cell lines. High constitutive NF-kappaB DNA-binding activity was detected in all chemoresistant cell lines. The upregulated NF-kappaB activity was composed of NF-kappaB subunits p50 and p65. Four out of five resistant cell lines constitutively overexpressed NF-kappaB p50 and p63 mRNA and protein. One resistant cell line with the highest NF-kappaB DNA-binding activity showed normal p50 and p65 protein expression. No NF-kappaB gene amplification was detected in resistant cell lines. Transient exposure of wild-type RKOWT and H630(WT) cells to 5-FU induced NF-kappaB DNA-binding activity but had no effect on NF-kappaB protein expression in these cells, Our results indicate that high constitutive NF-kappaB activity caused by its gene overexpression is an intrinsic character of TS inhibitor-resistant cells. NF-kappaB can antagonise anticancer drug-induced apoptosis. High NF-kappaB expression and nuclear activity in TS inhibitor-resistant cancer cells may play an important role in the chemoresistance. (C) 2003 Cancer Research UK.

    Original languageEnglish
    Pages (from-to)624-629
    Number of pages5
    JournalBritish Journal of Cancer
    Volume88
    Issue number4
    DOIs
    Publication statusPublished - 2003

    Keywords

    • NF-kappa B
    • I kappa B alpha
    • 5-FU
    • tomudex
    • chemoresistance
    • INDUCIBLE CHEMORESISTANCE
    • TRANSCRIPTION FACTORS
    • COLORECTAL-CANCER
    • INDUCED APOPTOSIS
    • ACTIVATION
    • THERAPY
    • MECHANISMS
    • CPT-11
    • GENES

    Cite this

    Constitutive nuclear factor-kappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitor-resistant tumour cells. / Wang, Weiguang; Cassidy, J.

    In: British Journal of Cancer, Vol. 88, No. 4, 2003, p. 624-629.

    Research output: Contribution to journalArticle

    @article{17cd7360476d4202927348dca564b6aa,
    title = "Constitutive nuclear factor-kappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitor-resistant tumour cells",
    abstract = "In this study, the gene copy number, mRNA and protein expression levels and nuclear DNA-binding activity of nuclear factor kappa B (NF-kappaB) were compared in a panel of five pairs of thymidylate synthase (TS) inhibitor-resistant and wild-type parent cancer cell lines. High constitutive NF-kappaB DNA-binding activity was detected in all chemoresistant cell lines. The upregulated NF-kappaB activity was composed of NF-kappaB subunits p50 and p65. Four out of five resistant cell lines constitutively overexpressed NF-kappaB p50 and p63 mRNA and protein. One resistant cell line with the highest NF-kappaB DNA-binding activity showed normal p50 and p65 protein expression. No NF-kappaB gene amplification was detected in resistant cell lines. Transient exposure of wild-type RKOWT and H630(WT) cells to 5-FU induced NF-kappaB DNA-binding activity but had no effect on NF-kappaB protein expression in these cells, Our results indicate that high constitutive NF-kappaB activity caused by its gene overexpression is an intrinsic character of TS inhibitor-resistant cells. NF-kappaB can antagonise anticancer drug-induced apoptosis. High NF-kappaB expression and nuclear activity in TS inhibitor-resistant cancer cells may play an important role in the chemoresistance. (C) 2003 Cancer Research UK.",
    keywords = "NF-kappa B, I kappa B alpha, 5-FU, tomudex, chemoresistance, INDUCIBLE CHEMORESISTANCE, TRANSCRIPTION FACTORS, COLORECTAL-CANCER, INDUCED APOPTOSIS, ACTIVATION, THERAPY, MECHANISMS, CPT-11, GENES",
    author = "Weiguang Wang and J. Cassidy",
    year = "2003",
    doi = "10.1038/sj.bjc.6600753",
    language = "English",
    volume = "88",
    pages = "624--629",
    journal = "British Journal of Cancer",
    issn = "0007-0920",
    publisher = "Nature Publishing Group",
    number = "4",

    }

    TY - JOUR

    T1 - Constitutive nuclear factor-kappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitor-resistant tumour cells

    AU - Wang, Weiguang

    AU - Cassidy, J.

    PY - 2003

    Y1 - 2003

    N2 - In this study, the gene copy number, mRNA and protein expression levels and nuclear DNA-binding activity of nuclear factor kappa B (NF-kappaB) were compared in a panel of five pairs of thymidylate synthase (TS) inhibitor-resistant and wild-type parent cancer cell lines. High constitutive NF-kappaB DNA-binding activity was detected in all chemoresistant cell lines. The upregulated NF-kappaB activity was composed of NF-kappaB subunits p50 and p65. Four out of five resistant cell lines constitutively overexpressed NF-kappaB p50 and p63 mRNA and protein. One resistant cell line with the highest NF-kappaB DNA-binding activity showed normal p50 and p65 protein expression. No NF-kappaB gene amplification was detected in resistant cell lines. Transient exposure of wild-type RKOWT and H630(WT) cells to 5-FU induced NF-kappaB DNA-binding activity but had no effect on NF-kappaB protein expression in these cells, Our results indicate that high constitutive NF-kappaB activity caused by its gene overexpression is an intrinsic character of TS inhibitor-resistant cells. NF-kappaB can antagonise anticancer drug-induced apoptosis. High NF-kappaB expression and nuclear activity in TS inhibitor-resistant cancer cells may play an important role in the chemoresistance. (C) 2003 Cancer Research UK.

    AB - In this study, the gene copy number, mRNA and protein expression levels and nuclear DNA-binding activity of nuclear factor kappa B (NF-kappaB) were compared in a panel of five pairs of thymidylate synthase (TS) inhibitor-resistant and wild-type parent cancer cell lines. High constitutive NF-kappaB DNA-binding activity was detected in all chemoresistant cell lines. The upregulated NF-kappaB activity was composed of NF-kappaB subunits p50 and p65. Four out of five resistant cell lines constitutively overexpressed NF-kappaB p50 and p63 mRNA and protein. One resistant cell line with the highest NF-kappaB DNA-binding activity showed normal p50 and p65 protein expression. No NF-kappaB gene amplification was detected in resistant cell lines. Transient exposure of wild-type RKOWT and H630(WT) cells to 5-FU induced NF-kappaB DNA-binding activity but had no effect on NF-kappaB protein expression in these cells, Our results indicate that high constitutive NF-kappaB activity caused by its gene overexpression is an intrinsic character of TS inhibitor-resistant cells. NF-kappaB can antagonise anticancer drug-induced apoptosis. High NF-kappaB expression and nuclear activity in TS inhibitor-resistant cancer cells may play an important role in the chemoresistance. (C) 2003 Cancer Research UK.

    KW - NF-kappa B

    KW - I kappa B alpha

    KW - 5-FU

    KW - tomudex

    KW - chemoresistance

    KW - INDUCIBLE CHEMORESISTANCE

    KW - TRANSCRIPTION FACTORS

    KW - COLORECTAL-CANCER

    KW - INDUCED APOPTOSIS

    KW - ACTIVATION

    KW - THERAPY

    KW - MECHANISMS

    KW - CPT-11

    KW - GENES

    U2 - 10.1038/sj.bjc.6600753

    DO - 10.1038/sj.bjc.6600753

    M3 - Article

    VL - 88

    SP - 624

    EP - 629

    JO - British Journal of Cancer

    JF - British Journal of Cancer

    SN - 0007-0920

    IS - 4

    ER -